Orthofix Medical Inc - Asset Resilience Ratio
Orthofix Medical Inc (OFIX) has an Asset Resilience Ratio of 0.15% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Orthofix Medical Inc (OFIX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2023)
This chart shows how Orthofix Medical Inc's Asset Resilience Ratio has changed over time. See how leveraged is Orthofix Medical Inc's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Orthofix Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Orthofix Medical Inc market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.33 Million | 0.15% |
| Total Liquid Assets | $1.33 Million | 0.15% |
Asset Resilience Insights
- Limited Liquidity: Orthofix Medical Inc maintains only 0.15% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Orthofix Medical Inc Industry Peers by Asset Resilience Ratio
Compare Orthofix Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Orthofix Medical Inc (2000–2023)
The table below shows the annual Asset Resilience Ratio data for Orthofix Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -0.50% | $-4.65 Million | $925.32 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $466.64 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $405.35 Million | -- |
| 2016-12-31 | 2.87% | $10.69 Million | $372.10 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $400.22 Million | -- |
| 2014-12-31 | 8.76% | $34.42 Million | $393.19 Million | +3.19pp |
| 2013-12-31 | 5.56% | $23.76 Million | $427.10 Million | +1.34pp |
| 2012-12-31 | 4.23% | $21.31 Million | $504.28 Million | -2.55pp |
| 2011-12-31 | 6.77% | $47.10 Million | $695.55 Million | +2.97pp |
| 2010-12-31 | 3.80% | $22.94 Million | $603.99 Million | +1.83pp |
| 2009-12-31 | 1.97% | $11.63 Million | $590.47 Million | +0.01pp |
| 2008-12-31 | 1.96% | $11.00 Million | $561.22 Million | +0.10pp |
| 2007-12-31 | 1.86% | $16.45 Million | $885.66 Million | +1.01pp |
| 2006-12-31 | 0.85% | $7.30 Million | $862.28 Million | -2.06pp |
| 2005-12-31 | 2.90% | $13.76 Million | $473.86 Million | -0.41pp |
| 2004-12-31 | 3.32% | $14.30 Million | $431.10 Million | +2.83pp |
| 2000-12-31 | 0.49% | $932.00K | $190.43 Million | -- |
About Orthofix Medical Inc
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhanc… Read more